arcoris bio AG Verified listing Verified listing

  • Swiss Biotech Association
    Member

arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.

Products, services, technology

Reagents based on our MUSE technology for multiplex immunofluorescence, IHC, FISH, FACS, LFA or ELISA.

Cooperation possibilities

MUSE is a highly versatile, cost-efficient reagent technology that enables true multiplexing for IHC, immunofluorescence and FISH—and extends effortlessly to FACS, ELISA, LFA, and other assay platforms. We offer our technology in a B2B model to reagent, instrument and diagnostics partners.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2022
  • Number of employees in Switzerland
    1-9

You may also be interested in